opc 12759 has been researched along with Temporomandibular Disorders in 2 studies
rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izawa, T | 2 |
| Hutami, IR | 2 |
| Tanaka, E | 2 |
| Mori, H | 1 |
| Shinohara, T | 1 |
| Mino-Oka, A | 1 |
| Iwasa, A | 1 |
1 review available for opc 12759 and Temporomandibular Disorders
| Article | Year |
|---|---|
Potential Role of Rebamipide in Osteoclast Differentiation and Mandibular Condylar Cartilage Homeostasis.
Topics: Alanine; Animals; Antioxidants; Cartilage, Articular; Cell Differentiation; Homeostasis; Humans; Man | 2018 |
1 other study available for opc 12759 and Temporomandibular Disorders
| Article | Year |
|---|---|
Rebamipide Attenuates Mandibular Condylar Degeneration in a Murine Model of TMJ-OA by Mediating a Chondroprotective Effect and by Downregulating RANKL-Mediated Osteoclastogenesis.
Topics: Administration, Oral; Alanine; Animals; Anti-Inflammatory Agents; Apoptosis; Arthritis, Experimental | 2016 |